A best evidence topic in thoracic surgery was written according to a structured protocol. The question addressed was: In wpatients over 70 years of age with lung cancerx is wlung resectionx when compared with wnon-surgical treatmentx justified in terms of wpostoperative morbidity, mortality and quality of lifex? Altogether more than 297 papers were found using the reported search, of which 12 represented the best evidence to answer the clinical question. The authors, journal, date and country of publication, patient group studied, study type, relevant outcomes and results of these papers are tabulated. We conclude that patients over 70 years of age undergoing anatomical lung resection respond as well as younger patients in terms of morbidity, mortality and residual quality of life (QoL). Collective analysis of the papers reveals no significant difference in five-year survival rates following surgery for early stage disease (stage I non-small cell lung cancer: -70 years; 69-77%, )70 years; 59-78%), although, elderly patients currently receive far higher rates of palliative care (30-47% in patients 65-70 years vs. 8% in patients under 65 years). Additionally, 30-day mortality rates (5.7% -70 years vs. 1.3-3.3% )70 years), length of hospital stay w1.3 days vs. 1 day (video-assisted mini-thoracotomy) and 4.6 vs. 4.9-5.2 days (thoracotomy) for -70 years vs.
Introduction
A best evidence topic was constructed according to a structured protocol. This is fully described in the ICVTS w1x.
Three-part question
In wpatients over 70 years of age with lung cancerx is wlung resectionx when compared with wnon-surgical treatmentx justified in terms of wpostoperative morbidity, mortality and quality of lifex?
Clinical scenario
An 84-year-old man is on your ward having being referred from clinic following symptoms leading to a diagnosis of stage I non-small cell lung cancer (NSCLC) although otherwise in good health with no other cardiopulmonary disease.
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You decide a lobectomy would be potentially curative but are aware of the risks associated with operating on elderly patients and wonder if these outweigh the long-term benefits in terms of prolonging the quality and duration of the patient's life. You carry out a literature search for the evidence.
Search strategy
wexp pneumonectomy OR exp pulmonary surgical proceduresyOR lobectomy.mp OR lung resection.mpx AND wexp mortalityyOR exp survival rateyOR exp quality of lifeyx AND welderly.mp OR exp agedx Medline 1950-December 2009 using OVID interface.
Search outcome
Two hundred and ninety-seven papers were found using the reported search. From these, 12 were identified that provided the best evidence to answer the question. These are presented in Table 1 . A. Chambers et al. / Interactive CardioVascular and Thoracic Surgery 10 (2010) Stage III 23% 36% 4-year mortality SCLC, small cell lung cancer; ICU, intensive care unit; NS, non-significant; Ps, performance status; COPD, chronic obstructive pulmonary disease; LOS, length of stay.
Results
The largest prospective longitudinal evaluation of quality of life (QoL) in elderly patients undergoing pulmonary resection was conducted by Burfeind et al. )70 years: 56.7 months, Psnon-significant (NS)x. Schulte et al. w3x also found global QoL to be equivalent between those )70 years and -70 years although role functioning (P-0.001) and social functioning (P-0.001) were lower in those -70 years.
Balduyck et al. w4x prospectively studied QoL in 60 septuagenarians undergoing either lobectomy (ns49) or pneumonectomy (ns11). Significant differences in physical functioning w6 months postoperatively (MPO) (6 MPO, Ps0.045), role functioning (3 MPO, Ps0.035), social functioning (6 MPO, Ps0.006, 12 MPO, Ps0.001) and general pain (6 MPO, Ps0.037)x were found in favour of lobectomy patients. Five-year survival rates were 0.62"0.12 (analysed using the Kaplan -Meier estimator) in the lobectomy group and 0.36"0.16 in the pneumonectomy group (PsNS).
Salati et al. w5x assessed lobectomy and pnemonectomy resections on residual QoL in patients -70 (ns133) and those over 70 (ns85), years. The physical component summary (PCS) (50.3 vs. 50, Ps0.7) and mental component summary (MCS) (50.6 vs. 49, Ps0.2) were equivalent. Highrisk and low-risk elderly patients responded equally in residual QoL.
Owonikoko et al. w6x conducted a retrospective population study of 316,682 patients undergoing lung cancer therapy. Overall, five-year survival rate decreased with increasing age (-70, 70-79 or G80 years was 15.5%, 12.3% and 7.4%, respectively, P-0.0001) although local therapy (radiation or surgery) was offered to the elderly far less frequently (palliative care being 19%, 28% or 47%, respectively). In those offered surgery, five-year survival rates were comparable (63.2%, 58.4%, 61.4%, respectively).
Sigel et al. w7x retrospectively analysed 27,859 cases of confirmed, stage I NSCLC. Rates of surgical resections declined from 95% in patients -60 years to 79% in patients G80 years. Five-year relative survival rates were lower in males G80 years (63.5%) compared with those -60 years (69.2%), but similar in women or unresected patients, regardless of gender.
Peake et al. w8x conducted a retrospective study in 48 UK hospital trusts. Overall, 6% of all patients )75 years were offered surgery, rising to 15% in patients with early stage NSCLC and no chronic obstructive pulmonary disease (COPD) (19% and 33%, respectively, for those -65 years). In all patients, five-year mortality rates were 42% in -65 years and 58% )75 years for low-risk patients, this was 23% and 41%, respectively.
Cangemi et al. w9x showed that epidermoid carcinoma and multiple tumour nodules were poor prognostic factors and, in their cohort of 283 patients, were more common in the elderly wepidermoid carcinoma (P-0.05) and multiple tumour nodules (P-0.001)x. Additionally, pneumonectomy had a worse outcome (Ps0.00001), and survival rates were similar between young and old.
Ciriaco et al. w10x looked prospectively at 76 patients aged )70 years, treated surgically for NSCLC. Postoperative complications arose in 15 cases (19.7%), 30-day operative mortality was 1.3% and 54-month survival rate was 53%. Twelve-month mortality was similar in all surgery types and stages of disease but correlated to severity of concomitant cardiopulmonary disease (P-0.05).
In 2001, Tovar w11x assessed video-assisted mini-thoracotomy for lung resection to determine whether elderly patients benefit from an accelerated recovery as those aged -70 years. Thirty-day mortality occurred in 5.7% (two patients; -70 years) and 3.3% (one patient; )70 years). Mean length of stay (LOS) was 1.3 days (-70 years) and one day in )70 years. Sullivan et al. w12x addressed pulmonary function in young (62.6"6.1 years) and elderly patients (74.5"3.6 years) following lobectomy for early stage NSCLC. Postoperative complications occurred in 32% of young patients (ns12) and 48% of elderly patients (ns12). FEV (F s1.06; Ps0.31) and functional vital capacity (FVC) (F s0.94; 1,59 Ps0.34) were NS. Cerfolio and Bryant w13x conducted a nested case control study of 726 patients (-70 years, ns363, )70 years, ns363) who underwent complete pulmonary resection for NSCLC. Length of hospital stay, operative mortality and morbidity were statistically equivalent, although neo-adjuvant therapy was a risk factor in the elderly wodds ratio (OR) 2.8, 95% confidence interval (CI) 1.14-7.41x. Additionally, elderly patients had a better five-year survival rate with stage I NSCLC (78% vs. 69%, Ps0.01), while all other stages were similar.
Clinical bottom line
In patients with early stage NSCLC, pulmonary resection provides the best form of treatment in terms of survival rate and residual QoL. Many surgeons, however, will not offer surgery to patients )70 years because of the additional risk associated with operating on this cohort, and limited long-term benefits they perceive this will offer. Here, several prospective and large population studies have shown unanimously, that patients )70 years of age respond as well as younger patients in all outcome measures pertaining to morbidity, mortality and QoL postoperatively, and should receive aggressive surgical management if considered fit for surgery, in accordance with the British Thoracic Society guidelines.
